Inventors list

Assignees list

Classification tree browser

Top 100 Inventors

Top 100 Assignees


Cropp

Gillian F. Cropp, San Francisco, CA US

Patent application numberDescriptionPublished
20090197852Method of treating breast cancer using 17-AAG or 17-AG or a prodrug of either in combination with a HER2 inhibitor - A method for treating a breast cancer in a subject by administering 17-allylamino-17-demethoxy-geldanamycin (17-AAG) or 17-amino-17-demethoxygeldanamycin (17-AG), or a prodrug of either 17-AAG or 17-AG, in combination with a HER2 inhibitor. 08-06-2009

Patent applications by Gillian F. Cropp, San Francisco, CA US

Martin Cropp, Christchurch NZ

Patent application numberDescriptionPublished
20100089836OIL DRIER REGENERATOR - A regeneration circuit for the in situ regeneration of an inline adsorbent filter, said filter being part of a normal circuit that is configured to remove one or more contaminant from a fluid circulated through a machine; the regeneration circuit includes a regeneration unit configured to remove one or more contaminant from a contaminated fluid creating a regenerated fluid, such that in operation the regenerated fluid is pumped from the regeneration unit and through the filter extracting the or each contaminant from the filter creating the contaminated fluid, this contaminated fluid then returns to the regeneration unit for contaminant removal, the pressure and flow rate of the regenerated fluid through the filter are maintained at a level that ensures minimal damage to the filter; said machine is isolated from the inline filter during regeneration.04-15-2010

Michael E. Cropp, Lagrangeville, NY US

Patent application numberDescriptionPublished
20080300946METHODS, SYSTEMS, AND COMPUTER PROGRAM PRODUCTS FOR IMPLEMENTING AN END-TO-END PROJECT MANAGEMENT SYSTEM - Methods, systems and computer program products for implementing an end-to-end integrated product development management system are provided. A method includes providing a user system with a link to a data source and an analysis tool via a user interface in response to a project opportunity selection for a proposed product. The method also includes receiving results of an analysis performed by the user system in response to implementing the analysis tool, and creating a project record for the project opportunity selection in response to determining an approval of the project opportunity selection. The method further includes creating a project plan by mapping data fields in the project record to corresponding data entries relating to a project phase, project task, project task tool, project task timetable, project task measurement, data source, and project team selected by the user system via the user interface.12-04-2008

T. Ashton Cropp, San Diego, CA US

Patent application numberDescriptionPublished
20100160618Expanding the eukaryotic genetic code - This invention provides compositions and methods for producing translational components that expand the number of genetically encoded amino acids in eukaryotic cells. The components include orthogonal tRNAs, orthogonal aminoacyl-tRNA synthetases, orthogonal pairs of tRNAs/synthetases and unnatural amino acids. Proteins and methods of producing proteins with unnatural amino acids in eukaryotic cells are also provided.06-24-2010

T. Ashton Cropp, Bethesda, MD US

Patent application numberDescriptionPublished
20080227195Expanding the eukaryotic genetic code - This invention provides compositions and methods for producing translational components that expand the number of genetically encoded amino acids in eukaryotic cells. The components include orthogonal tRNAs, orthogonal aminoacyl-tRNA synthetases, orthogonal pairs of tRNAs/synthetases and unnatural amino acids. Proteins and methods of producing proteins with unnatural amino acids in eukaryotic cells are also provided.09-18-2008

Patent applications by T. Ashton Cropp, Bethesda, MD US

Thomas Ashton Cropp, Bethesda, MD US

Patent application numberDescriptionPublished
20090004702CODON SPECIFIC MUTAGENESIS - Materials and Methods are provided for replacing one or more amino acids in a polypeptide with an amino acid of choice to form mutant proteins. Both naturally and non-naturally occurring amino acids can be inserted. A population of mutant proteins can be created in which an amino acid residue has replaced an existing residue at random locations along the primary sequence of the protein. The provided techniques allow for the study of proteins and development of proteins with improved functionalities.01-01-2009